• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic
  • Guestorial: Demand for Nationalization of Healthcare Services in India
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea
  • Phablecare Raises ₹187 Cr In Funding
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»BioControversial»Undisclosed industry payments rampant in drug-trial papers in Australia

Undisclosed industry payments rampant in drug-trial papers in Australia

0
By Biotech Express on March 29, 2022 BioControversial, SARS- CoV2 & COVID-19 Updates

One in four Australian medical researchers involved in drug trials failed to declare money they had received from pharmaceutical companies when submitting journal manuscripts, a study reports.

The authors cross-checked statements on financial conflicts of interest listed by Australian authors of 120 drug trials published in the first eight months of 2020 against a database of company-made payments reported to Medicines Australia, the country’s pharmaceutical-industry association. The research, published in the Journal of General Internal Medicine1 this month, is one of only a few studies outside the United States to examine discrepancies between drug-company payments made to health professionals and author disclosure statements.

The study found that missing or incomplete declarations were common. Half of the trials and a quarter of the 323 Australian authors involved had at least one undeclared financial conflict (see ‘Undeclared conflicts’), with undisclosed payments ranging from AU$140 to AU$97,600 (US$100 to US$71,000) for consulting, advisory meetings, speaker fees and education events.

The results are sobering and similar to those from US studies2, which “suggests that the fundamental problem of conflict-of-interest non-disclosure is a persistent one” in clinical research — evident across journals, across countries and over time, says James Baraldi, a neuroscientist at the University of Pittsburgh, Pennsylvania.

The Australian study found that roughly half of the Australian trial investigators with incomplete disclosures failed to declare any conflicts of interest when company reports showed they had been paid, while 43% of trials had partial declarations

Undeclared financial ties are especially concerning in drug trials, in which transparency is paramount given the deep-rooted influence of pharmaceutical-industry funding that can sway prescribing practices3 and distort research outcomes4, adds Mintzes.

Publicly accessible and government-run databases have helped to expose financial ties between the pharmaceutical industry and medical researchers mainly in the United States, where drug companies and device manufacturers have been legally required to report payments to health-care providers since 2014.

Despite this public scrutiny, evidence suggests that medical researchers are continuing to under-report conflicts of interest, which undermines integrity in science, says Cameron Taheri, a physician-researcher at the University of Calgary in Canada. A 2021 meta-analysis of mostly US studies2, led by Taheri, found that, on average, two-thirds of clinical-trial authors omitted at least one financial conflict in published works.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports

COVID-19 scientists are facing an avalanche of abuse, Science survey shows

19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea

Leave A Reply Cancel Reply

Current Issue – April 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports April 25, 2022
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows April 24, 2022
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic April 24, 2022
  • Guestorial: Demand for Nationalization of Healthcare Services in India April 24, 2022
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea April 15, 2022
  • Phablecare Raises ₹187 Cr In Funding April 11, 2022
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events April 9, 2022
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers April 8, 2022
  • Bose Institute Scientists earn retraction due to manipulation April 5, 2022
  • WHO suspends Covaxin supply to UN agencies April 4, 2022
  • Lockdowns, Not the Pandemic, Created Havoc April 1, 2022
  • WHO selects Biological E to transfer mRNA COVID vaccine tech April 1, 2022
  • Dr. Reddy’s Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany April 1, 2022
  • New Zealand High Court ENDS Vaccine Mandate: “It’s a Gross Violation of Human Rights” April 1, 2022
  • S&T Ministry to support startup in medical implants March 31, 2022
  • FDA Clears Marketing of Genome-Edited Beef Cattle March 30, 2022
  • Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey March 30, 2022
  • Undisclosed industry payments rampant in drug-trial papers in Australia March 29, 2022
  • Fraud Trial of Former Theranos Executive Ramesh’ Sunny’ Balwani Begins March 29, 2022
  • Substandard, fake medical products increased by almost 47% from 2020 to 2021 during pandemic: report March 29, 2022
  • Editorial: Biofuels in India – a perfect waste to wealth and net zero emission energy option March 29, 2022
  • Bharat Biotech and BIOFABRI partner to develop, manufacture and distribute novel TB vaccine March 28, 2022
  • Fibroheal raises debt funding from BIRAC March 28, 2022
  • Editorial – Energy, Renewable Energy and Bioenergy March 28, 2022
  • IISc, India to set up public health centre with Rs105 cr funding from philanthropist March 27, 2022
  • Tamil Nadu makes scientifically dubious claim on vaccines in the Supreme Court March 27, 2022
  • Guest Article: GENE EDITED-CRISPERED FLOWERS: Blooming with grace March 27, 2022
  • Dr. Anthony Fauci, Biden admin operated with missing data as CDC issued pandemic guidance, emails show March 25, 2022
  • Contents – February 2022 March 3, 2022
  • Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka February 26, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • Articles- News Reports
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • BioResearch – Industry
  • Biotech – Agriculture
  • Biotech – Healthcare
  • Biotech – Supplies
  • Biotech News – Featured
  • Biotech News – India
  • Biotech News – Industry
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.